Bharat Parenterals Share Price

CMP as on23-May-22 15:26

₹ 344.35
-14.8 -4.12%

Open

₹ 365.00

Turnover (lac)

₹ 1

Prev. Close

₹ 359.15

Day's Vol (shares)

₹ 4,540

Day's Range

₹ 343.80
₹ 377.10

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Jan-2022 - -
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 inter alia to consider and approve The unaudited financial results of the Company for the Quarter ended on December 31 2021. In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 09th February, 2022 has considered and approved the Unaudited Financial Results for the Quarter ended 31st December, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter ended 31st December, 2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 01.30 p.m. and concluded at 02:00 p.m. Request you to please take the same on record. (As per BSE Announcement Dated on 09/02/2022)
Board Meeting - 04-Jan-2022 - -
Change in the address of registered office of the company due to renumbering and consolidation of the existing land, the land of the company remains the same. The new numbering and registered office address is Survey No. 144A, Jarod-Samlaya Road, Haripura, Savli, Vadodara -391520, Gujarat. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we bring to your kind attention that the Board of Directors of the company at their meeting held on 04th January,2021 accorded their approval for following matter: Appointment of Cost Auditor Change in registered office address Removal of address other than R/o where all or any books of account and papers are maintained (As per BSE Announcement Dated on 06/01/2022)
Board Meeting - 22-Oct-2021 - -
Quarterly Results In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 30th October, 2021, has considered and approved the Unaudited Financial Results for the Quarter and half year ended 30th September, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter and Half year ended 30th September, 2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 02.30 p.m. and concluded at 03:00 p.m. (As Per BSE Announcement Dated on 30/10/2021)
Board Meeting - 03-Aug-2021 - -
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve 1. The unaudited financial results of the Company for the Quarter ended on June 30, 2021. In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 11th August, 2021, has considered and approved the Unaudited Financial Results for the Quarter ended 30th June,2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter ended 30th June,2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 11.00 a.m. and concluded at 11:40 a.m. Request you to please take the same on record. (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 27-May-2021 - -
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2021 ,inter alia, to consider and approve With reference to the above, we would like to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the meeting of Board of Directors of the Company is scheduled to be held on 05th June, 2021, at the registered office of the Company situated at Survey No. 144 & 146, Jarod Samlaya road, Village Haripura., Ta. Savli, Vadodara-391520, to consider and approve: 1. The Audited financial results of the Company for the Quarter and Year ended on 31st March, 2021. Moreover, in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 vide our letter dated 31st March, 2021, the trading window shall remain closed from 01st April, 2021 till the completion of 48 hours after the declaration of Financial Results (both days inclusive). You are requested to take the same on record. Outcome of the Board Meeting and Submission of Audited Financial Results (Standalone and Consolidated) for the Year ended 31st March, 2021. (As Per BSE Announcement dated on 05.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity